FDA Approves First Targeted Therapy for IDH-Mutant Glioma with Companion Diagnostic

FDA Approves VYLOY™ as a New Targeted Therapy for Advanced Gastric and GEJ Cancer

AI-Powered Cancer Drug LP-184 Receives FDA Fast-Track Designation for Glioblastoma

FDA Approves TruSight Cancer Test for Matching Patients with Targeted Therapies

Nipocalimab Submitted to FDA for Treatment of Generalized Myasthenia Gravis

Novel Cancer Drug PT217 Wins FDA Orphan Drug Status for Neuroendocrine Carcinoma

Mixed-Reality System, HipInsight, Receives FDA Approval for Hip Surgery

FDA Approves Neffy: First Nasal Spray for Emergency Allergic Reactions

Iptacopan, the First CI, Wins FDA Accelerated Approval for IgA Nephropathy

FDA Approves Vorasidenib as First Targeted Therapy for G2 IDH-Mutant Glioma

FDA Approves Expanded Use of Dostarlimab for Treatment of Endometrial Cancers

FDA Approves Johnson's Daratumumab Plus VRd for Newly Diagnosed Multiple Myeloma

FDA Approves Expanded Use of Xembify for Immunodeficiency Treatment

Anixa's CAR-T Therapy for Ovarian Cancer Earns FDA IND Approval

FDA Clears ZW191 for Clinical Trials: Novel Drug Targets NSCLC and Ovarian Cancer

FDA Approves Kisunla, a Novel Alzheimer's Therapy Targeting Amyloid Plaques

FDA Grants Fast-Track Designation to SYNC-T SV-102 for Prostate Cancer

FDA Approves Trials for ZW171: A Novel Bispecific Antibody for Hard-to-Treat Cancers

FDA Approves Grifols' Yimmugo® for Primary Immunodeficiency, Marking a Milestone

Spinogenix's Daily Pill SPG302 Receives FDA IND Nod for ALS Treatment

New Treatment for AA Hepatitis: Larsucosterol Earns FDA Breakthrough Designation

FDA Approves IMDELLTRA for Lung Cancer After a 40% Response Rate

A New Horizon in Oncology: FDA Approves the First-Ever mRNA Cancer Vaccine

FDA Grants Full Approval for Tivdak® to Treat Recurrent or Metastatic Cervical Cancer

GenFleet Receives FDA Approval for P3 Trial of GFH925 in Colorectal Cancer Treatment

Transformative One-Time Gene Therapy: FDA Approves Pfizer's BEQVEZ, for Hemophilia B

FDA Approves Lutathera as First Treatment for Pediatric Neuroendocrine Tumors

FDA Approves New Imaging System to Enhance Tumor Detection in Cancer Surgery

Roche's Blood Test for Alzheimer's Earns FDA Breakthrough Device Designation

LSTA1 (Certepetide) Wins FDA Orphan Drug Status for Osteosarcoma Treatment